Case Control Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Jun 7, 2017; 23(21): 3864-3875
Published online Jun 7, 2017. doi: 10.3748/wjg.v23.i21.3864
Figure 3
Figure 3 Efficacy of studied miRNAs in hepatocellular carcinoma, hepatitis C virus categorization using receiver operating characteristics curve analysis. Hepatocellular carcinoma (n = 224) and hepatitis C virus (n = 250). AUC: Area under the curve.